- call +1-201-465-4211
- email sales@marketsandresearch.biz
- Call +1-201-465-4211
- Email: sales@marketsandresearch.biz
The Alectinib market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest study, due to COVID-19 pandemic, the global Alectinib market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Unresectable NSCLC accounting for % of the Alectinib global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While 150mg*140 Capsules segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Alectinib include Roche, Everest Pharmaceuticals, , , and , etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Alectinib market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
150mg*140 Capsules
150mg*28 Capsules
20mg*1 Capsule
40mg*1 Capsule
150mg*26 Capsules
Market segment by Application can be divided into
Unresectable NSCLC
Advanced NSCLC
Recurrent NSCLC
Other
The key market players for global Alectinib market are listed below:
Roche
Everest Pharmaceuticals
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Alectinib product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Alectinib, with price, sales, revenue and global market share of Alectinib from 2019 to 2022.
Chapter 3, the Alectinib competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Alectinib breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Alectinib market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Alectinib.
Chapter 13, 14, and 15, to describe Alectinib sales channel, distributors, customers, research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Alectinib Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Alectinib Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 150mg*140 Capsules
1.2.3 150mg*28 Capsules
1.2.4 20mg*1 Capsule
1.2.5 40mg*1 Capsule
1.2.6 150mg*26 Capsules
1.3 Market Analysis by Application
1.3.1 Overview: Global Alectinib Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Unresectable NSCLC
1.3.3 Advanced NSCLC
1.3.4 Recurrent NSCLC
1.3.5 Other
1.4 Global Alectinib Market Size & Forecast
1.4.1 Global Alectinib Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Alectinib Sales in Volume (2017-2028)
1.4.3 Global Alectinib Price (2017-2028)
1.5 Global Alectinib Production Capacity Analysis
1.5.1 Global Alectinib Total Production Capacity (2017-2028)
1.5.2 Global Alectinib Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Alectinib Market Drivers
1.6.2 Alectinib Market Restraints
1.6.3 Alectinib Trends Analysis
2 Manufacturers Profiles
2.1 Roche
2.1.1 Roche Details
2.1.2 Roche Major Business
2.1.3 Roche Alectinib Product and Services
2.1.4 Roche Alectinib Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Everest Pharmaceuticals
2.2.1 Everest Pharmaceuticals Details
2.2.2 Everest Pharmaceuticals Major Business
2.2.3 Everest Pharmaceuticals Alectinib Product and Services
2.2.4 Everest Pharmaceuticals Alectinib Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Alectinib Breakdown Data by Manufacturer
3.1 Global Alectinib Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Alectinib Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Alectinib
3.4 Market Concentration Rate
3.4.1 Top 3 Alectinib Manufacturer Market Share in 2021
3.4.2 Top 6 Alectinib Manufacturer Market Share in 2021
3.5 Global Alectinib Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Alectinib Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Alectinib Market Size by Region
4.1.1 Global Alectinib Sales in Volume by Region (2017-2028)
4.1.2 Global Alectinib Revenue by Region (2017-2028)
4.2 North America Alectinib Revenue (2017-2028)
4.3 Europe Alectinib Revenue (2017-2028)
4.4 Asia-Pacific Alectinib Revenue (2017-2028)
4.5 South America Alectinib Revenue (2017-2028)
4.6 Middle East and Africa Alectinib Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Alectinib Sales in Volume by Type (2017-2028)
5.2 Global Alectinib Revenue by Type (2017-2028)
5.3 Global Alectinib Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Alectinib Sales in Volume by Application (2017-2028)
6.2 Global Alectinib Revenue by Application (2017-2028)
6.3 Global Alectinib Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Alectinib Sales by Type (2017-2028)
7.2 North America Alectinib Sales by Application (2017-2028)
7.3 North America Alectinib Market Size by Country
7.3.1 North America Alectinib Sales in Volume by Country (2017-2028)
7.3.2 North America Alectinib Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Alectinib Sales by Type (2017-2028)
8.2 Europe Alectinib Sales by Application (2017-2028)
8.3 Europe Alectinib Market Size by Country
8.3.1 Europe Alectinib Sales in Volume by Country (2017-2028)
8.3.2 Europe Alectinib Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Alectinib Sales by Type (2017-2028)
9.2 Asia-Pacific Alectinib Sales by Application (2017-2028)
9.3 Asia-Pacific Alectinib Market Size by Region
9.3.1 Asia-Pacific Alectinib Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Alectinib Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Alectinib Sales by Type (2017-2028)
10.2 South America Alectinib Sales by Application (2017-2028)
10.3 South America Alectinib Market Size by Country
10.3.1 South America Alectinib Sales in Volume by Country (2017-2028)
10.3.2 South America Alectinib Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Alectinib Sales by Type (2017-2028)
11.2 Middle East & Africa Alectinib Sales by Application (2017-2028)
11.3 Middle East & Africa Alectinib Market Size by Country
11.3.1 Middle East & Africa Alectinib Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Alectinib Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Alectinib and Key Manufacturers
12.2 Manufacturing Costs Percentage of Alectinib
12.3 Alectinib Production Process
12.4 Alectinib Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Alectinib Typical Distributors
13.3 Alectinib Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer
List of Tables
Table 1. Global Alectinib Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Alectinib Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Roche Basic Information, Manufacturing Base and Competitors
Table 4. Roche Major Business
Table 5. Roche Alectinib Product and Services
Table 6. Roche Alectinib Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Everest Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 8. Everest Pharmaceuticals Major Business
Table 9. Everest Pharmaceuticals Alectinib Product and Services
Table 10. Everest Pharmaceuticals Alectinib Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Global Alectinib Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Pcs)
Table 12. Global Alectinib Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 13. Market Position of Manufacturers in Alectinib, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 14. Global Alectinib Production Capacity by Company, (K Pcs): 2020 VS 2021
Table 15. Head Office and Alectinib Production Site of Key Manufacturer
Table 16. Alectinib New Entrant and Capacity Expansion Plans
Table 17. Alectinib Mergers & Acquisitions in the Past Five Years
Table 18. Global Alectinib Sales by Region (2017-2022) & (K Pcs)
Table 19. Global Alectinib Sales by Region (2023-2028) & (K Pcs)
Table 20. Global Alectinib Revenue by Region (2017-2022) & (USD Million)
Table 21. Global Alectinib Revenue by Region (2023-2028) & (USD Million)
Table 22. Global Alectinib Sales by Type (2017-2022) & (K Pcs)
Table 23. Global Alectinib Sales by Type (2023-2028) & (K Pcs)
Table 24. Global Alectinib Revenue by Type (2017-2022) & (USD Million)
Table 25. Global Alectinib Revenue by Type (2023-2028) & (USD Million)
Table 26. Global Alectinib Price by Type (2017-2022) & (USD/Pcs)
Table 27. Global Alectinib Price by Type (2023-2028) & (USD/Pcs)
Table 28. Global Alectinib Sales by Application (2017-2022) & (K Pcs)
Table 29. Global Alectinib Sales by Application (2023-2028) & (K Pcs)
Table 30. Global Alectinib Revenue by Application (2017-2022) & (USD Million)
Table 31. Global Alectinib Revenue by Application (2023-2028) & (USD Million)
Table 32. Global Alectinib Price by Application (2017-2022) & (USD/Pcs)
Table 33. Global Alectinib Price by Application (2023-2028) & (USD/Pcs)
Table 34. North America Alectinib Sales by Country (2017-2022) & (K Pcs)
Table 35. North America Alectinib Sales by Country (2023-2028) & (K Pcs)
Table 36. North America Alectinib Revenue by Country (2017-2022) & (USD Million)
Table 37. North America Alectinib Revenue by Country (2023-2028) & (USD Million)
Table 38. North America Alectinib Sales by Type (2017-2022) & (K Pcs)
Table 39. North America Alectinib Sales by Type (2023-2028) & (K Pcs)
Table 40. North America Alectinib Sales by Application (2017-2022) & (K Pcs)
Table 41. North America Alectinib Sales by Application (2023-2028) & (K Pcs)
Table 42. Europe Alectinib Sales by Country (2017-2022) & (K Pcs)
Table 43. Europe Alectinib Sales by Country (2023-2028) & (K Pcs)
Table 44. Europe Alectinib Revenue by Country (2017-2022) & (USD Million)
Table 45. Europe Alectinib Revenue by Country (2023-2028) & (USD Million)
Table 46. Europe Alectinib Sales by Type (2017-2022) & (K Pcs)
Table 47. Europe Alectinib Sales by Type (2023-2028) & (K Pcs)
Table 48. Europe Alectinib Sales by Application (2017-2022) & (K Pcs)
Table 49. Europe Alectinib Sales by Application (2023-2028) & (K Pcs)
Table 50. Asia-Pacific Alectinib Sales by Region (2017-2022) & (K Pcs)
Table 51. Asia-Pacific Alectinib Sales by Region (2023-2028) & (K Pcs)
Table 52. Asia-Pacific Alectinib Revenue by Region (2017-2022) & (USD Million)
Table 53. Asia-Pacific Alectinib Revenue by Region (2023-2028) & (USD Million)
Table 54. Asia-Pacific Alectinib Sales by Type (2017-2022) & (K Pcs)
Table 55. Asia-Pacific Alectinib Sales by Type (2023-2028) & (K Pcs)
Table 56. Asia-Pacific Alectinib Sales by Application (2017-2022) & (K Pcs)
Table 57. Asia-Pacific Alectinib Sales by Application (2023-2028) & (K Pcs)
Table 58. South America Alectinib Sales by Country (2017-2022) & (K Pcs)
Table 59. South America Alectinib Sales by Country (2023-2028) & (K Pcs)
Table 60. South America Alectinib Revenue by Country (2017-2022) & (USD Million)
Table 61. South America Alectinib Revenue by Country (2023-2028) & (USD Million)
Table 62. South America Alectinib Sales by Type (2017-2022) & (K Pcs)
Table 63. South America Alectinib Sales by Type (2023-2028) & (K Pcs)
Table 64. South America Alectinib Sales by Application (2017-2022) & (K Pcs)
Table 65. South America Alectinib Sales by Application (2023-2028) & (K Pcs)
Table 66. Middle East & Africa Alectinib Sales by Region (2017-2022) & (K Pcs)
Table 67. Middle East & Africa Alectinib Sales by Region (2023-2028) & (K Pcs)
Table 68. Middle East & Africa Alectinib Revenue by Region (2017-2022) & (USD Million)
Table 69. Middle East & Africa Alectinib Revenue by Region (2023-2028) & (USD Million)
Table 70. Middle East & Africa Alectinib Sales by Type (2017-2022) & (K Pcs)
Table 71. Middle East & Africa Alectinib Sales by Type (2023-2028) & (K Pcs)
Table 72. Middle East & Africa Alectinib Sales by Application (2017-2022) & (K Pcs)
Table 73. Middle East & Africa Alectinib Sales by Application (2023-2028) & (K Pcs)
Table 74. Alectinib Raw Material
Table 75. Key Manufacturers of Alectinib Raw Materials
Table 76. Direct Channel Pros & Cons
Table 77. Indirect Channel Pros & Cons
Table 78. Alectinib Typical Distributors
Table 79. Alectinib Typical Customers
List of Figures
Figure 1. Alectinib Picture
Figure 2. Global Alectinib Revenue Market Share by Type in 2021
Figure 3. 150mg*140 Capsules
Figure 4. 150mg*28 Capsules
Figure 5. 20mg*1 Capsule
Figure 6. 40mg*1 Capsule
Figure 7. 150mg*26 Capsules
Figure 8. Global Alectinib Revenue Market Share by Application in 2021
Figure 9. Unresectable NSCLC
Figure 10. Advanced NSCLC
Figure 11. Recurrent NSCLC
Figure 12. Other
Figure 13. Global Alectinib Revenue, (USD Million) & (K Pcs): 2017 & 2021 & 2028
Figure 14. Global Alectinib Revenue and Forecast (2017-2028) & (USD Million)
Figure 15. Global Alectinib Sales (2017-2028) & (K Pcs)
Figure 16. Global Alectinib Price (2017-2028) & (USD/Pcs)
Figure 17. Global Alectinib Production Capacity (2017-2028) & (K Pcs)
Figure 18. Global Alectinib Production Capacity by Geographic Region: 2022 VS 2028
Figure 19. Alectinib Market Drivers
Figure 20. Alectinib Market Restraints
Figure 21. Alectinib Market Trends
Figure 22. Global Alectinib Sales Market Share by Manufacturer in 2021
Figure 23. Global Alectinib Revenue Market Share by Manufacturer in 2021
Figure 24. Alectinib Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 25. Top 3 Alectinib Manufacturer (Revenue) Market Share in 2021
Figure 26. Top 6 Alectinib Manufacturer (Revenue) Market Share in 2021
Figure 27. Global Alectinib Sales Market Share by Region (2017-2028)
Figure 28. Global Alectinib Revenue Market Share by Region (2017-2028)
Figure 29. North America Alectinib Revenue (2017-2028) & (USD Million)
Figure 30. Europe Alectinib Revenue (2017-2028) & (USD Million)
Figure 31. Asia-Pacific Alectinib Revenue (2017-2028) & (USD Million)
Figure 32. South America Alectinib Revenue (2017-2028) & (USD Million)
Figure 33. Middle East & Africa Alectinib Revenue (2017-2028) & (USD Million)
Figure 34. Global Alectinib Sales Market Share by Type (2017-2028)
Figure 35. Global Alectinib Revenue Market Share by Type (2017-2028)
Figure 36. Global Alectinib Price by Type (2017-2028) & (USD/Pcs)
Figure 37. Global Alectinib Sales Market Share by Application (2017-2028)
Figure 38. Global Alectinib Revenue Market Share by Application (2017-2028)
Figure 39. Global Alectinib Price by Application (2017-2028) & (USD/Pcs)
Figure 40. North America Alectinib Sales Market Share by Type (2017-2028)
Figure 41. North America Alectinib Sales Market Share by Application (2017-2028)
Figure 42. North America Alectinib Sales Market Share by Country (2017-2028)
Figure 43. North America Alectinib Revenue Market Share by Country (2017-2028)
Figure 44. United States Alectinib Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 45. Canada Alectinib Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 46. Mexico Alectinib Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 47. Europe Alectinib Sales Market Share by Type (2017-2028)
Figure 48. Europe Alectinib Sales Market Share by Application (2017-2028)
Figure 49. Europe Alectinib Sales Market Share by Country (2017-2028)
Figure 50. Europe Alectinib Revenue Market Share by Country (2017-2028)
Figure 51. Germany Alectinib Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. France Alectinib Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. United Kingdom Alectinib Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. Russia Alectinib Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. Italy Alectinib Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. Asia-Pacific Alectinib Sales Market Share by Region (2017-2028)
Figure 57. Asia-Pacific Alectinib Sales Market Share by Application (2017-2028)
Figure 58. Asia-Pacific Alectinib Sales Market Share by Region (2017-2028)
Figure 59. Asia-Pacific Alectinib Revenue Market Share by Region (2017-2028)
Figure 60. China Alectinib Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Japan Alectinib Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Korea Alectinib Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. India Alectinib Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. Southeast Asia Alectinib Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. Australia Alectinib Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. South America Alectinib Sales Market Share by Type (2017-2028)
Figure 67. South America Alectinib Sales Market Share by Application (2017-2028)
Figure 68. South America Alectinib Sales Market Share by Country (2017-2028)
Figure 69. South America Alectinib Revenue Market Share by Country (2017-2028)
Figure 70. Brazil Alectinib Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 71. Argentina Alectinib Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 72. Middle East & Africa Alectinib Sales Market Share by Type (2017-2028)
Figure 73. Middle East & Africa Alectinib Sales Market Share by Application (2017-2028)
Figure 74. Middle East & Africa Alectinib Sales Market Share by Region (2017-2028)
Figure 75. Middle East & Africa Alectinib Revenue Market Share by Region (2017-2028)
Figure 76. Turkey Alectinib Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. Egypt Alectinib Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 78. Saudi Arabia Alectinib Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 79. South Africa Alectinib Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 80. Manufacturing Cost Structure Analysis of Alectinib in 2021
Figure 81. Manufacturing Process Analysis of Alectinib
Figure 82. Alectinib Industrial Chain
Figure 83. Sales Channel: Direct Channel vs Indirect Channel
Figure 84. Methodology
Figure 85. Research Process and Data Source
Please feel free to write an email to us or to use our electronic ticketing system.
